General Surgery of Beijing Jishuitan Hospital, The Fourth Clinical Medical College of Peking University, Beijing, China.
Front Endocrinol (Lausanne). 2021 Jul 27;12:704596. doi: 10.3389/fendo.2021.704596. eCollection 2021.
The staging system for patients with anaplastic thyroid cancer (ATC) was updated in the 8 edition of the American Joint Committee on Cancer Staging Manual. A cut-off age of 55 years was stipulated as a prognostic factor for differentiated thyroid cancer; however, age was not considered for ATC patients. To this end, this study investigated the relationship between age at diagnosis and prognosis of ATC patients.
The clinical information on ATC patients was acquired from the Surveillance, Epidemiology, and End Results Program public database. Youden's index and X-tile analyses were used to calculate the high-point age at diagnosis associated with prognosis. Cox proportional hazards models, Kaplan-Meier curves, and 1000-person-year were then used for verifying the accuracy of the high-point age.
After inclusion/exclusion criteria was applied, 586 patients were included in this study. The high-point age was determined to be 70 years by both the Youden's index and X-tile plot methods. The hazard ratio was 1.662 (95% confidence interval [CI]: 1.321-2.092), indicating that there was an increased risk of poor prognosis for patients > 70 years of age. The cancer-specific mortality rates per 1000-person-years for patients ≤ and > 70 years-old were 949.980 (95% CI: 827.323-1090.822) and 1546.667 (95% CI: 1333.114-1794.428), respectively. P-values were < 0.001 for the results shown above.
Our study found that age influenced the prognosis of ATC patients. Furthermore, we determined that the high-point age at diagnosis was 70 years and that > 70 years of age was associated with a poor prognosis. These results provide a useful addition to the staging manual and can improve the diagnosis, treatment strategies and prognosis of ATC patients.
美国癌症联合委员会(AJCC)第 8 版癌症分期手册更新了间变性甲状腺癌(ATC)患者的分期系统。55 岁被规定为分化型甲状腺癌的预后因素;然而,年龄并未被考虑用于 ATC 患者。为此,本研究调查了诊断时年龄与 ATC 患者预后之间的关系。
从监测、流行病学和最终结果(SEER)程序公共数据库中获取 ATC 患者的临床信息。采用 Youden 指数和 X-tile 分析来计算与预后相关的高诊断年龄点。然后使用 Cox 比例风险模型、Kaplan-Meier 曲线和 1000 人年来验证高年龄点的准确性。
应用纳入/排除标准后,本研究纳入了 586 名患者。Youden 指数和 X-tile 图方法均确定高年龄点为 70 岁。风险比为 1.662(95%置信区间[CI]:1.321-2.092),表明 70 岁以上患者预后不良的风险增加。诊断时年龄≤和>70 岁的患者每 1000 人年的癌症特异性死亡率分别为 949.980(95%CI:827.323-1090.822)和 1546.667(95%CI:1333.114-1794.428)。上述结果的 P 值均<0.001。
本研究发现年龄影响 ATC 患者的预后。此外,我们确定高诊断年龄点为 70 岁,>70 岁与预后不良相关。这些结果为分期手册提供了有用的补充,并可改善 ATC 患者的诊断、治疗策略和预后。